Algert Global LLC Boosts Holdings in Alignment Healthcare, Inc. (NASDAQ:ALHC)

Algert Global LLC increased its stake in Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 115.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 174,012 shares of the company's stock after purchasing an additional 93,109 shares during the period. Algert Global LLC owned approximately 0.09% of Alignment Healthcare worth $1,958,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. JPMorgan Chase & Co. grew its stake in Alignment Healthcare by 249.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 288,219 shares of the company's stock worth $3,407,000 after buying an additional 205,705 shares in the last quarter. Barclays PLC increased its stake in Alignment Healthcare by 144.1% in the third quarter. Barclays PLC now owns 193,446 shares of the company's stock valued at $2,287,000 after acquiring an additional 114,191 shares during the last quarter. US Bancorp DE raised its position in Alignment Healthcare by 6,544.2% during the fourth quarter. US Bancorp DE now owns 98,932 shares of the company's stock valued at $1,113,000 after purchasing an additional 97,443 shares in the last quarter. Franklin Resources Inc. purchased a new position in shares of Alignment Healthcare in the 4th quarter worth about $732,000. Finally, Proficio Capital Partners LLC purchased a new position in shares of Alignment Healthcare in the 4th quarter worth about $184,000. 86.19% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

ALHC has been the subject of a number of recent research reports. JPMorgan Chase & Co. boosted their target price on Alignment Healthcare from $14.00 to $17.00 and gave the stock a "neutral" rating in a research report on Thursday, March 6th. Barclays boosted their price objective on shares of Alignment Healthcare from $8.00 to $9.00 and gave the stock an "underweight" rating in a report on Friday, February 28th. William Blair reaffirmed an "outperform" rating on shares of Alignment Healthcare in a research note on Friday, February 28th. Stephens reiterated an "overweight" rating and issued a $17.00 target price on shares of Alignment Healthcare in a research report on Monday, February 24th. Finally, UBS Group upped their price target on shares of Alignment Healthcare from $16.00 to $17.00 and gave the company a "neutral" rating in a research report on Friday, May 2nd. One analyst has rated the stock with a sell rating, three have issued a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $17.17.

Insider Activity at Alignment Healthcare

In related news, COO Sebastian Burzacchi sold 6,694 shares of Alignment Healthcare stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $16.40, for a total transaction of $109,781.60. Following the completion of the transaction, the chief operating officer now directly owns 250,378 shares of the company's stock, valued at $4,106,199.20. This trade represents a 2.60% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO John E. Kao sold 554,713 shares of the company's stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $15.53, for a total transaction of $8,614,692.89. Following the completion of the sale, the chief executive officer now owns 4,733,664 shares in the company, valued at approximately $73,513,801.92. This trade represents a 10.49% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 2,076,977 shares of company stock worth $33,671,411 over the last quarter. Corporate insiders own 7.00% of the company's stock.

Alignment Healthcare Trading Up 7.8%

Shares of NASDAQ:ALHC traded up $1.10 during midday trading on Wednesday, hitting $15.15. 1,862,016 shares of the stock traded hands, compared to its average volume of 1,845,522. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82. The business's 50 day moving average is $17.30 and its two-hundred day moving average is $14.50. The stock has a market capitalization of $3.00 billion, a PE ratio of -19.68 and a beta of 1.32. Alignment Healthcare, Inc. has a one year low of $6.82 and a one year high of $21.06.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The company reported ($0.05) EPS for the quarter, beating analysts' consensus estimates of ($0.12) by $0.07. Alignment Healthcare had a negative return on equity of 108.69% and a negative net margin of 5.84%. The business had revenue of $926.93 million during the quarter, compared to analyst estimates of $889.83 million. During the same quarter in the prior year, the company posted ($0.25) EPS. Alignment Healthcare's quarterly revenue was up 47.5% compared to the same quarter last year. As a group, research analysts forecast that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.